Bench to Boardroom – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Bench to Boardroom

Pharmaconcepts

Science

Business

Frequency: 1 episode/11d. Total Eps: 5

Bench to Boardroom is a highly curated podcast for life sciences leaders who value signal over noise. Each concise episode distills the most relevant ideas, trends, and strategic insights shaping biotech, pharma, medtech, and healthcare today—always practical, always actionable. Select episodes feature distinguished guests sharing real-world perspectives from the front lines of innovation and leadership.

Read moreCollapse

Site

RSS

Apple

Data updated on 14/07/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

No links shared by this podcast

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 58%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

The New Economics of Launch

Season 1 · Episode 4

Monday, June 8, 2026 • Duration 10:33

In this episode of Bench to Boardroom, we examine why maximizing value across a life sciences portfolio increasingly requires an asset-specific, geography-agnostic approach rather than relying on the traditional “U.S. first, Europe second, rest of world later” launch model. Through examples in oncology/hematology, cell and gene therapy, and immunology, the discussion explores how launch sequencing, emerging regulatory pathways, evidence generation, market access strategy, and international pricing dynamics can materially influence net present value (NPV), time to patient access, and long-term commercial success. The episode argues that the most valuable portfolios of the future will be built not by following convention, but by strategically matching each asset with the launch sequence that optimizes both enterprise value and patient impact.

Read moreCollapse

The Technology Allocation Trap

Season 1 · Episode 3

Monday, May 25, 2026 • Duration 12:14

In this episode of Bench to Boardroom, we explore why not all technology investments in life sciences are created equal — and why following the hype around AI and digital transformation may generate far weaker returns than many executives expect. The discussion examines where emerging technologies can create meaningful strategic advantage across clinical development, commercialization, market access, launch sequencing, regulatory intelligence, manufacturing, and supply chain operations, while also highlighting where excessive or poorly targeted tech investment may lead to diminishing returns. Ultimately, the episode argues that the leaders who win with technology are not those investing the most, but those investing most intelligently — aligning technology with the realities of science, operations, and commercial execution.

Read moreCollapse

The New Launch Playbook

Season 1 · Episode 2

Monday, May 11, 2026 • Duration 12:23

Launching innovative medicines can no longer follow conventional precedent. The old formula -- U.S. first, Europe second, rest of world later -- is increasingly misaligned with the realities of today’s health policy, pricing, and market access environment.

And for some assets, following the traditional launch sequence may actually destroy long-term value.

Not because the science is flawed.

But because the strategy is.

Read moreCollapse

Portfolio Strategy

Season 1 · Episode 1

Monday, April 27, 2026 • Duration 11:51

The term Portfolio Strategy gets used constantly in life sciences. Board decks use it. Investors use it. Management teams use it. Consultants use it. But too often, portfolio strategy is treated as a static spreadsheet exercise -- ranking assets, cutting budgets, and reallocating headcount. In this episode, we discuss why (and how) real portfolio strategy is far more consequential than that.

Read moreCollapse

Inaugural Episode

Season 1

Friday, April 24, 2026 • Duration 03:50

Short trailer introducing the Bench to Boardroom podcast

Bench to Boardroom – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Bench to Boardroom – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify